Protein Labeling Market by Labeling Method (In Vitro, In Vivo and Bioorthogonal Labeling), Application (Mass Spectrometry, Immunological Techniques, and Protein Microarray), Product Type (Kits, Reagents and Services), and End Users (Research Laboratories, Hospitals and Diagnostic Centers, and Others) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Protein labeling is a process in biological research that uses molecular labels to create covalent bonds with the protein of interest. This helps in the detection and purification of the labeled protein and/or its binding associates. The process is carried out with the use of different labels such as, biotin, reporter enzymes, monoclonal antibodies, fluorophores, radioactive isotopes, and other tags. Specific labels are used to target a particular protein or nucleotide sequence and the labeling strategy is carefully selected and completed for each application. This process is helpful to identify proteins in tissues, cells, samples, and biochemical assays. The increase in healthcare and R&D expenditure and progress in proteomics research primarily drive the protein labeling market.

This market is estimated to reach $5,350 million by 2022 from $2,002 million in 2015, growing at a significant CAGR of 14.9% during the forecast period. Moreover, government investments on healthcare and R&D on the increase in the use of proteomics, and other applications such as diagnostics and therapeutics are expected to drive the market. However, lack of skilled professionals and accelerated market consolidation is expected to restrict the market growth.

The growth in competition has led to collaborations and product launch by major players in the protein labeling market. For instance, in September 2016, Kaneka Corporation’s subsidiary, Eurogentec S.A. signed an agreement with Koram Biotech Corp. (KBC), one of the largest life science reagent and services companies in South Korea, to be the new distributor for its products. This collaboration has helped Kaneka to make a smooth entry in the South Korean market. Likewise, in June 2016, F. Hoffmann-LA Roche AG (Roche) launched a new product, Cobas E 801 module, a high-volume testing immunoassay solution that had high flexibility and continuous operation, which saves time and reduces the amount of waste generated during the process.

KEY BENEFITS

    The global protein labeling market report provides an extensive analysis of the current market trends and future estimations prevailing in the market.

    The market estimations from 2014 to 2022 are based on high-end analysis of the key developments.

    The market scenario is comprehensively analyzed with respect to the application, product type, labeling method, and end users.

    Recent developments and key manufacturers are listed and analyzed to understand the competitive market scenario.

    In-depth analysis, based on geography provides an understanding of the regional market, which assists in strategic business planning.

KEY MARKET SEGMENTS

By Labeling Method

    In Vitro Labeling

        Nanoparticle Labeling

        Site-Specific Labeling

        Dye-Based Labeling

        Co-Translational Labeling

        Enzymatic Labeling

    In Vivo Labeling

        Radioactive Labeling

        Photoreactive Labeling

    Bioorthogonal Labeling

By Application

    Cell-Based Assays

    Fluorescence Microscopy

    Mass Spectrometry

    Immunological Techniques

    Protein Microarray

By Product Type

    Kits

    Reagents

        Enzymes

        Monoclonal Antibodies

        Probes/Tags

        Protein

        Other Reagents

    Services

By End Users

    Research Laboratories

    Hospitals and Diagnostic Centers

    Others

By Geography

    North America

        U.S.

        Canada

        Mexico

    Europe

        Germany

        France

        UK

        Rest of Europe

    Asia-Pacific

        Japan

        China

        India

        Australia

        Rest of Asia-Pacific

    LAMEA

        Brazil

        Republic of South Africa

        Rest of LAMEA

The key players profiled in this report include:

    General Electric Company

    Kaneka Corporation

    LI-COR, Inc.

    Merck & Co., Inc.

    New England Biolabs, Inc.

    PerkinElmer, Inc.

    Promega Corporation

    F. Hoffmann-LA Roche AG

    Seracare Life Sciences, Inc.

    Thermo Fisher Scientific, Inc.

The other players of the protein labeling market include (companies not profiled in the report):

    Qiagen N.V.

    Active Motif, Inc.

    Takara Bio USA, Inc.

    Candor Bioscience GMBHa

    Innova Biosciences Ltd.

    Luminex Corporation

    Bio-Rad Laboratories

    Agilent Technologies, Inc.

    Caprion Biosciences

    Nanotemper Technologies GMBH

    Biotium, Inc.

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION

1.2. KEY BENEFITS

1.3. KEY MARKET SEGMENTS

1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE

3.2. KEY FINDINGS

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.3. PATENT ANALYSIS

3.3.1. Patent analysis, by year

3.3.2. Patent analysis, by country

3.4. TOP IMPACTING FACTORS

3.4.1. Drivers

3.4.1.1. Rise in healthcare expenditure

3.4.1.2. Increase in R&D investments

3.4.1.3. Growth in proteomics research

3.4.2. Restraints

3.4.2.1. Lack of skilled professionals

3.4.3. Opportunities

3.4.3.1. Training the professionals

3.4.3.2. Greater potency with reduced costs and increasing affordability

CHAPTER 4 GLOBAL PROTEIN LABELING MARKET, BY LABELING METHOD

4.1. OVERVIEW

4.1.1. Market size & forecast

4.1.2. In vitro labeling

4.1.2.1. Market size & forecast

4.1.2.2. Nanoparticle labeling

4.1.2.2.1. MARKET SIZE & FORECAST

4.1.2.3. Site-specific Labeling

4.1.2.3.1. MARKET SIZE & FORECAST

4.1.2.4. Dye-based

4.1.2.4.1. MARKET SIZE & FORECAST

4.1.2.5. Co-translational labeling

4.1.2.5.1. MARKET SIZE & FORECAST

4.1.2.6. Enzymatic Labeling

4.1.2.6.1. MARKET SIZE & FORECAST

4.1.3. In vivo labeling

4.1.3.1. Market size & forecast

4.1.3.2. Radioactive labeling

4.1.3.2.1. MARKET SIZE & FORECAST

4.1.3.3. Photoreactive labeling

4.1.3.3.1. MARKET SIZE & FORECAST

4.1.4. Bioorthogonal labeling

4.1.4.1. Market size & forecast

CHAPTER 5 GLOBAL PROTEIN LABELING MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.1.2. Cellbased assays

5.1.2.1. Key market trends

5.1.2.2. Key growth factors and opportunities

5.1.2.3. Market size and forecast

5.1.3. Fluorescence microscopy

5.1.3.1. Key market trends

5.1.3.2. Key growth factors and opportunities

5.1.3.3. Market size and forecast

5.1.4. Mass spectrometry

5.1.4.1. Key market trends

5.1.4.2. Key growth factors and opportunities

5.1.4.3. Market size and forecast

5.1.5. Immunological techniques

5.1.5.1. Key market trends

5.1.5.2. Key growth factors and opportunities

5.1.5.3. Market size and forecast

5.1.6. Protein microarray

5.1.6.1. Key market trends

5.1.6.2. Key growth factors and opportunities

5.1.6.3. Market size and forecast

CHAPTER 6 GLOBAL PROTEIN LABELING MARKET, BY PRODUCT TYPE

6.1. OVERVIEW

6.1.1. Market size & forecast

6.2. KITS

6.2.1. Market size & forecast

6.3. REAGENTS

6.3.1. Market size & forecast

6.3.2. Enzymes

6.3.2.1. Market size & forecast

6.3.3. Monoclonal antibodies

6.3.3.1. Market size & forecast

6.3.4. Probes/Tags

6.3.4.1. Market size & forecast

6.3.5. Proteins

6.3.5.1. Market size & forecast

6.3.6. Other Reagents

6.3.6.1. Market size & forecast

6.4. SERVICES

6.4.1. Market size & forecast

CHAPTER 7 GLOBAL PROTEIN LABELING MARKET, BY END USERS

7.1. OVERVIEW

7.1.1. Market size & forecast

7.2. RESEARCH LABORATORIES

7.2.1. Market size & forecast

7.3. HOSPITALS AND DIAGNOSTIC CENTERS

7.3.1. Market size & forecast

7.4. OTHERS

7.4.1. Market size & forecast

CHAPTER 8 GLOBAL PROTEIN LABELING MARKET, BY GEOGRAPHY

8.1. OVERVIEW

8.1.1. Market size & forecast

8.2. NORTH AMERICA

8.2.1. Key market trends

8.2.2. Key growth factors and opportunities

8.2.3. Market size & forecast

8.2.4. U.S.

8.2.5. Canada

8.2.6. Mexico

8.3. EUROPE

8.3.1. Key market trends

8.3.2. Key growth factors and opportunities

8.3.3. Market size & forecast

8.3.4. Germany

8.3.5. France

8.3.6. UK

8.3.7. Rest of Europe

8.4. ASIA-PACIFIC

8.4.1. Key market trends

8.4.2. Key growth factors and opportunities

8.4.3. Market size & forecast

8.4.4. Japan

8.4.5. China

8.4.6. Australia

8.4.7. India

8.4.8. Rest of Asia-Pacific

8.5. LAMEA

8.5.1. Key market trends

8.5.2. Key growth factors and opportunities

8.5.3. Market size & forecast

8.5.4. Brazil

8.5.5. Republic of South Africa

8.5.6. Rest of LAMEA

CHAPTER 9 COMPANY PROFILES

9.1. GENERAL ELECTRIC COMPANY

9.1.1. Company overview

9.1.2. Operating business segments

9.1.3. Business performance

9.1.4. Key strategic moves & developments

9.2. PERKINELMER, INC.

9.2.1. Company overview

9.2.2. Operating business segments

9.2.3. Business performance

9.2.4. Key strategic moves & developments

9.3. THERMO FISHER SCIENTIFIC, INC.

9.3.1. Company overview

9.3.2. Operating business segments

9.3.3. Business performance

9.3.4. Key strategic moves & developments

9.4. MERCK & CO., INC.

9.4.1. Company overview

9.4.2. Operating business segments

9.4.3. Business performance

9.4.4. Key strategic moves & developments

9.5. F. Hoffmann-La Roche AG

9.5.1. Company overview

9.5.2. Operating business segments

9.5.3. Business performance

9.5.4. Key strategic moves & developments

9.6. KANEKA CORPORATION

9.6.1. Company overview

9.6.2. Operating business segments

9.6.3. Business performance

9.6.4. Key strategic moves & developments

9.7. PROMEGA CORPORATION

9.7.1. Company overview

9.7.2. Operating business segments

9.7.3. Business performance

9.7.4. Key strategic moves & developments

9.8. LI-COR, INC.

9.8.1. Company overview

9.8.2. Operating business segments

9.8.3. Business performance

9.8.4. Key strategic moves & developments

9.9. NEW ENGLAND BIOLABS, INC.

9.9.1. Company overview

9.9.2. Operating business segments

9.9.3. Business performance

9.9.4. Key strategic moves & developments

9.10. SERACARE LIFE SCIENCES, INC.

9.10.1. Company overview

9.10.2. Operating business segments

9.10.3. Business performance

9.10.4. Key strategic moves & developments

The other companies in the protein labeling market include:

Qiagen N.V.

Active Motif, Inc.

Takara Bio USA, Inc.

Candor Bioscience GMBH

Innova Biosciences Ltd.

Luminex Corporation

Bio-Rad Laboratories

Agilent Technologies, Inc.

Caprion Biosciences

Nanotemper Technologies GMBH

Biotium, Inc.

*Profiles of these players are not included. The same will be included on request

TABLE 1. PATENTS REGISTERED/APPROVED, BY YEAR (20132016)

TABLE 2. PATENTS REGISTERED/APPROVED, BY COUNTRY (2013-2016)

TABLE 3. GLOBAL PROTEIN LABELING MARKET, BY LABELING METHOD

TABLE 4. IN VITRO PROTEIN LABELING MARKET, BY REGION

TABLE 5. IN VITRO PROTEIN LABELING MARKET, BY TYPE

TABLE 6. NANOPARTICLE PROTEIN LABELING MARKET, BY REGION

TABLE 7. SITE-SPECIFIC PROTEIN LABELING MARKET, BY REGION

TABLE 8. DYE-BASED PROTEIN LABELING MARKET, BY REGION

TABLE 9. CO-TRANSLATIONAL PROTEIN LABELING MARKET, BY REGION

TABLE 10. ENZYMATIC PROTEIN LABELING MARKET, BY REGION

TABLE 11. IN VIVO PROTEIN LABELING MARKET, BY REGION

TABLE 12. IN VIVO PROTEIN LABELING MARKET, BY TYPE

TABLE 13. RADIOACTIVE PROTEIN LABELING MARKET, BY REGION

TABLE 14. PHOTOREACTIVE PROTEIN LABELING MARKET, BY REGION

TABLE 15. BIOORTHOGONAL PROTEIN LABELING MARKET, BY REGION

TABLE 16. GLOBAL PROTEIN LABELING MARKET, BY APPLICATION

TABLE 17. CELL-BASED ASSAYS PROTEIN LABELING MARKET, BY REGION

TABLE 18. FLUORESCENCE MICROSCOPYPROTEIN LABELING MARKET, BY REGION

TABLE 19. MASS SPECTROMETRY PROTEIN LABELING MARKET, BY REGION

TABLE 20. IMMUNOLOGICAL TECHNIQUES PROTEIN LABELING MARKET, BY REGION

TABLE 21. PROTEIN MICROARRAY PROTEIN LABELING MARKET, BY REGION

TABLE 22. GLOBAL PROTEIN LABELING MARKET, BY PRODUCT TYPE

TABLE 23. PROTEIN LABELING KITS MARKET, BY REGION

TABLE 24. PROTEIN LABELING REAGENTS MARKET, BY REGION

TABLE 25. PROTEIN LABELING REAGENTS MARKET, BY TYPE

TABLE 26. ENZYME BASED PROTEIN LABELING REAGENTS MARKET, BY REGION

TABLE 27. MONOCLONAL ANTIBODIES BASED PROTEIN LABELING REAGENTS MARKET, BY REGION

TABLE 28. PROBES/TAGS BASED PROTEIN LABELING REAGENTS MARKET, BY REGION

TABLE 29. PROTEIN BASED PROTEIN LABELING REAGENTS MARKET, BY REGION

TABLE 30. OTHER REAGENTS USED IN PROTEIN LABELING MARKET, BY REGION

TABLE 31. PROTEIN LABELING SERVICES MARKET, BY REGION

TABLE 32. GLOBAL PROTEIN LABELING MARKET, BY END USERS

TABLE 33. RESEARCH LABORATORIES PROTEIN LABELING MARKET, BY REGION

TABLE 34. HOSPITALS AND DIAGNOSTIC CENTERS PROTEIN LABELING MARKET, BY REGION

TABLE 35. OTHER END USERS PROTEIN LABELING MARKET, BY REGION

TABLE 36. GLOBAL PROTEIN LABELING MARKET, BY REGION

TABLE 37. NORTH AMERICA PROTEIN LABELING MARKET, BY LABELING METHOD

TABLE 38. NORTH AMERICA PROTEIN LABELING MARKET, BY APPLICATION

TABLE 39. NORTH AMERICA PROTEIN LABELING MARKET, BY PRODUCT TYPE

TABLE 40. NORTH AMERICA PROTEIN LABELING MARKET, BY END USER

TABLE 41. NORTH AMERICA PROTEIN LABELING MARKET, BY COUNTRY

TABLE 42. EUROPE PROTEIN LABELING MARKET, BY LABELING METHOD

TABLE 43. EUROPE PROTEIN LABELING MARKET, BY APPLICATION

TABLE 44. EUROPE PROTEIN LABELING MARKET, BY PRODUCT TYPE

TABLE 45. EUROPE PROTEIN LABELING MARKET, BY END USER

TABLE 46. EUROPE PROTEIN LABELING MARKET, BY COUNTRY

TABLE 47. ASIA-PACIFIC PROTEIN LABELING MARKET, BY LABELING METHOD

TABLE 48. ASIA-PACIFIC PROTEIN LABELING MARKET, BY APPLICATION

TABLE 49. ASIA-PACIFIC PROTEIN LABELING MARKET, BY PRODUCT TYPE

TABLE 50. ASIA-PACIFIC PROTEIN LABELING MARKET, BY END USER

TABLE 51. ASIA-PACIFIC PROTEIN LABELING MARKET, BY COUNTRY

TABLE 52. LAMEA PROTEIN LABELING MARKET, BY LABELING METHOD

TABLE 53. LAMEA PROTEIN LABELING MARKET, BY APPLICATION

TABLE 54. LAMEA PROTEIN LABELING MARKET, BY PRODUCT TYPE

TABLE 55. LAMEA PROTEIN LABELING MARKET, BY END USER

TABLE 56. LAMEA PROTEIN LABELING MARKET, BY COUNTRY

TABLE 57. GE: COMPANY SNAPSHOT

TABLE 58. GE: OPERATING SEGMENTS

TABLE 59. PERKINELMER: COMPANY SNAPSHOT

TABLE 60. PERKINELMER: OPERATING SEGMENTS

TABLE 61. THERMO FISHER: COMPANY SNAPSHOT

TABLE 62. THERMO FISHER: OPERATING SEGMENTS

TABLE 63. MERCK: COMPANY SNAPSHOT

TABLE 64. MERCK: OPERATING SEGMENTS

TABLE 65. ROCHE: COMPANY SNAPSHOT

TABLE 66. ROCHE: OPERATING SEGMENTS

TABLE 67. KANEKA: COMPANY SNAPSHOT

TABLE 68. KANEKA: OPERATING SEGMENTS

TABLE 69. PROMEGA: COMPANY SNAPSHOT

TABLE 70. LI-COR: COMPANY SNAPSHOT

TABLE 71. NEB: COMPANY SNAPSHOT

TABLE 72. SERACARE: COMPANY SNAPSHOT FIGURE 1. SEGMENTATION

FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL PROTEIN LABELING MARKET, BY APPLICATION

FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20132016)

FIGURE 4. TOP WINNING STRATEGIES, BY COMPANY (20132016)

FIGURE 5. PATENTS REGISTERED/APPROVED, BY YEAR (20132016)

FIGURE 6. PATENTS REGISTERED/APPROVED, BY COUNTRY (20132016)

FIGURE 7. U.S. PROTEIN LABELING MARKET, 2014-2022

FIGURE 8. CANADA PROTEIN LABELING MARKET, 2014-2022

FIGURE 9. MEXICO PROTEIN LABELING MARKET, 2014-2022

FIGURE 10. GERMANY PROTEIN LABELING MARKET, 2014-2022

FIGURE 11. FRANCE PROTEIN LABELING MARKET, 2014-2022

FIGURE 12. UK PROTEIN LABELING MARKET, 2014-2022

FIGURE 13. REST OF EUROPE PROTEIN LABELING MARKET, 2014-2022

FIGURE 14. JAPAN PROTEIN LABELING MARKET, 2014-2022

FIGURE 15. CHINA PROTEIN LABELING MARKET, 2014-2022

FIGURE 16. AUSTRALIA PROTEIN LABELING MARKET, 2014-2022

FIGURE 17. INDIA PROTEIN LABELING MARKET, 2014-2022

FIGURE 18. REST OF ASIA-PACIFIC PROTEIN LABELING MARKET, 2014-2022

FIGURE 19. BRAZIL PROTEIN LABELING MARKET, 2014-2022

FIGURE 20. REPUBLIC OF SOUTH AFRICA PROTEIN LABELING MARKET, 2014-2022

FIGURE 21. REST OF LAMEA PROTEIN LABELING MARKET, 2014-2022

FIGURE 22. GE FINANCIALS

FIGURE 23. PERKINELMER FINANCIALS

FIGURE 24. THERMO FISHER FINANCIALS

FIGURE 25. MERCK FINANCIALS

FIGURE 26. ROCHE FINANCIALS

FIGURE 27. KANEKA FINANCIALS

FIGURE 28. PROMEGA FINANCIAL